Two Sigma Investments LP cut its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 11.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 317,733 shares of the technology company's stock after selling 40,354 shares during the quarter. Two Sigma Investments LP owned 0.28% of Amdocs worth $27,052,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of DOX. Pzena Investment Management LLC grew its stake in shares of Amdocs by 4.3% during the 4th quarter. Pzena Investment Management LLC now owns 6,634,549 shares of the technology company's stock worth $564,866,000 after purchasing an additional 270,810 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Amdocs by 2.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company's stock worth $274,681,000 after purchasing an additional 87,801 shares during the period. Vanguard Group Inc. grew its stake in shares of Amdocs by 16.1% during the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after purchasing an additional 426,035 shares during the period. Wellington Management Group LLP grew its stake in shares of Amdocs by 25.4% during the 4th quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after purchasing an additional 543,490 shares during the period. Finally, Pacer Advisors Inc. grew its stake in shares of Amdocs by 7.4% during the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock worth $154,587,000 after purchasing an additional 125,654 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Price Performance
Amdocs stock traded down $0.26 during trading on Friday, reaching $91.36. The company had a trading volume of 690,093 shares, compared to its average volume of 685,860. The firm's 50-day simple moving average is $87.87 and its 200 day simple moving average is $87.20. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.61. The firm has a market capitalization of $10.31 billion, a PE ratio of 21.20, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.07. Amdocs had a net margin of 10.19% and a return on equity of 18.89%. The firm had revenue of $1.13 billion for the quarter, compared to analysts' expectations of $1.12 billion. During the same quarter last year, the company earned $1.56 EPS. The firm's revenue for the quarter was down 9.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.
Amdocs Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Monday, June 30th will be paid a $0.527 dividend. The ex-dividend date is Monday, June 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.31%. Amdocs's dividend payout ratio is currently 44.21%.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th.
View Our Latest Stock Report on Amdocs
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.